Robin HGA van den Biggelaar

7PUBLICATIONS
9CO-AUTHORS
Gene and molecular therapyMedical mycologyMedical bacteriologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Animal protection (incl. pests and pathogens)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 21, 2026
mTORC1 inhibitors rapamycin and everolimus as host-directed therapy for tuberculosis.

Robin H G A van den Biggelaar, Tom H M Ottenhoff

|Jan 06, 2026
Comparative Transcriptomic Analysis of Human Macrophages During Mycobacterium avium Versus Mycobacterium tuberculosis Infection.

Gül Kilinç, Robin H G A van den Biggelaar, Tom H M Ottenhoff

|Jul 01, 2025
Indolocarbazoles as host-directed therapeutics against intracellular infections by methicillin-resistant Staphylococcus aureus.

Robin H G A van den Biggelaar, David Erdkamp, Adriëtte W de Visser

|Sep 22, 2021
Overcoming scientific barriers in the transition from in vivo to non-animal batch testing of human and veterinary vaccines.

Robin H G A van den Biggelaar, Marcel H N Hoefnagel, Rob J Vandebriel

|Nov 13, 2020
Macrophage Activation Assays to Evaluate the Immunostimulatory Capacity of Avibacterium paragallinarum in A Multivalent Poultry Vaccine.

Robin H G A van den Biggelaar, Willem van Eden, Victor P M G Rutten

|Aug 23, 2020
Training of Primary Chicken Monocytes Results in Enhanced Pro-Inflammatory Responses.

Michel B Verwoolde, Robin H G A van den Biggelaar, Jürgen van Baal

Pageof 2

Frequent Collaborators

4 joint publications

Christine A Jansen

2 joint publications

Victor P M G Rutten

1 joint publications

Michel B Verwoolde

1 joint publications

Aart Lammers